NASDAQ:PPBT

Purple Biotech Stock Forecast

etoro logo Buy PPBT
*Your capital is at risk
$1.45
-0.0200 (-1.36%)
At Close: Jul 20, 2026
AI Analysis AI Analysis of PPBT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PPBT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Monday for Purple Biotech Ltd.
(Updated on Jul 20, 2026)

Sell candidate since Jul 16, 2026 Loss -1.36%

The Purple Biotech Ltd. stock price fell by -1.36% on the last day (Monday, 20th Jul 2026) from $1.47 to $1.45. During the last trading day the stock fluctuated 4.86% from a day low at $1.44 to a day high of $1.51. The price has fallen in 6 of the last 10 days and is down by -16.18% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 thousand shares and in total, 5 thousand shares were bought and sold for approximately $7.38 thousand.

Given the current short-term trend, the stock is expected to fall -71.84% during the next 3 months and, with a 90% probability hold a price between $0.213 and $0.408 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PPBT Signals & Forecast

There are mixed signals in the stock today. The Purple Biotech Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.47 and $1.98. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Tuesday, July 14, 2026, and so far it has risen 2.84%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Purple Biotech Ltd. stock

Purple Biotech Ltd. finds support from accumulated volume at $1.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0700 between high and low, or 4.86%. For the last week the stock has had daily average volatility of 7.16%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PPBT) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Purple Biotech Ltd. to open at $1.47, and during the day (based on 14 day Average True Range), to move between $1.37 and $1.53, which gives a possible trading interval of +/-$0.158 (+/-11.56%) up or down from last closing price. If Purple Biotech Ltd. takes out the full calculated possible swing range there will be an estimated 11.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.43 (1.38%) than the resistance at $1.54 (6.21%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Purple Biotech Ltd. stock A Buy?

Purple Biotech Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.498 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $1.47 ( 1.15%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PPBT Performance

Trading levels for PPBT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.54 5.98%
R2 1.51 4.13%
R1 1.49 2.99%
Price 1.45
S1 1.44 -0.695%
S2 1.42 -1.83%
S3 1.40 -3.68%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.69 16.55%
R2 1.58 8.97%
R1 1.54 6.21%
Price 1.45
S1 1.43 -1.38%
S2 1.41 -2.76%
S3 0 -

FAQ

What is the symbol for Purple Biotech Ltd. Stock and on which exchange is it traded?
The symbol for Purple Biotech Ltd. is PPBT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Purple Biotech Ltd. Stock?
Purple Biotech Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Purple Biotech Ltd. Stock?
Purple Biotech Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Purple Biotech Ltd. Stock.

What's the current price of Purple Biotech Ltd. Stock?
As of the end of day on the Jul 20, 2026, the price of an Purple Biotech Ltd. (PPBT) share was $1.45.

What is the 52-week high and low for Purple Biotech Ltd. Stock?
The 52-week high for Purple Biotech Ltd. Stock is $31.60 and the 52-week low is $1.35.

What is the market capitalization of Purple Biotech Ltd. Stock?
As of the Jul 20, 2026, the market capitalization of Purple Biotech Ltd. is 200.222K.

When is the next earnings date for Purple Biotech Ltd.?
The upcoming earnings date for Purple Biotech Ltd. is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT PURPLE BIOTECH LTD.
Purple Biotech
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1b/2 clinical trials for the treatment of non-small cell lung cancer and panc...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE